Freeline Therapeutics Holdings plc Quarterly Cash and Cash Equivalents, at Carrying Value in USD from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Freeline Therapeutics Holdings plc quarterly Cash and Cash Equivalents, at Carrying Value history and growth rate from Q4 2018 to Q3 2023.
  • Freeline Therapeutics Holdings plc Cash and Cash Equivalents, at Carrying Value for the quarter ending September 30, 2023 was $29.5M, a 55.3% decline year-over-year.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $29.5M -$36.4M -55.3% Sep 30, 2023 6-K 2023-12-01
Q2 2023 $38.8M -$51.2M -56.9% Jun 30, 2023 6-K 2023-08-15
Q1 2023 $55.4M -$57.7M -51% Mar 31, 2023 6-K 2023-05-30
Q4 2022 $47.3M -$70.4M -59.8% Dec 31, 2022 6-K 2023-12-01
Q3 2022 $65.8M -$70.5M -51.7% Sep 30, 2022 6-K 2023-12-01
Q2 2022 $90M -$74.7M -45.4% Jun 30, 2022 6-K 2023-08-15
Q1 2022 $113M -$82.7M -42.2% Mar 31, 2022 6-K 2023-05-30
Q4 2021 $118M -$112M -48.8% Dec 31, 2021 20-F 2023-04-04
Q3 2021 $136M -$114M -45.6% Sep 30, 2021 6-K 2022-11-15
Q2 2021 $165M +$58.1M +54.5% Jun 30, 2021 6-K 2022-08-09
Q1 2021 $196M +$143M +273% Mar 31, 2021 6-K 2022-05-10
Q4 2020 $230M +$156M +212% Dec 31, 2020 20-F 2023-04-04
Q3 2020 $251M Sep 30, 2020 6-K 2021-11-09
Q2 2020 $107M +$51.2M +92.2% Jun 30, 2020 6-K 2021-08-16
Q1 2020 $52.5M Mar 31, 2020 6-K 2021-05-17
Q4 2019 $73.7M +$57.7M +359% Dec 31, 2019 20-F 2022-03-31
Q2 2019 $55.5M Jun 30, 2019 6-K 2020-10-29
Q4 2018 $16.1M Dec 31, 2018 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.